Data as of Mar 11
| +1.88 / +1.71%|
The 14 analysts offering 12-month price forecasts for Salix Pharmaceuticals Ltd have a median target of 122.50, with a high estimate of 131.00 and a low estimate of 96.00. The median estimate represents a +9.66% increase from the last price of 111.71.
The current consensus among 15 polled investment analysts is to Buy stock in Salix Pharmaceuticals Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.